Meet with the Veracyte® Breast Cancer team at the ESMO Breast Cancer 2024 congress at booth #17.

Learn more about the Prosigna® Breast Cancer Assay, the breast cancer risk of recurrence test that confidently guides treatment decisions.

Prosigna Breast Cancer Assay

THE TEST to answer more than one question

Visit www.Prosigna.com for more information